Ozaslan, E. Et Al. 2017. Efficacy and safety of cetuximab plus FOLFOX in second-line and third-line therapy in metastatic colorectal cancer.. Journal of B.U.ON. : official journal of the Balkan Union of Oncology , vol.22, no.4 , 863-868.

Ozaslan, E., Topaloglu, U. S., Inanc, M., Gokmen Erdem, U., Demir, H., Arpaci, E., ... Metin Seker, M.(2017). Efficacy and safety of cetuximab plus FOLFOX in second-line and third-line therapy in metastatic colorectal cancer.. Journal of B.U.ON. : official journal of the Balkan Union of Oncology , vol.22, no.4, 863-868.

Ozaslan, Ersin Et Al. "Efficacy and safety of cetuximab plus FOLFOX in second-line and third-line therapy in metastatic colorectal cancer.," Journal of B.U.ON. : official journal of the Balkan Union of Oncology , vol.22, no.4, 863-868, 2017

Ozaslan, Ersin Et Al. "Efficacy and safety of cetuximab plus FOLFOX in second-line and third-line therapy in metastatic colorectal cancer.." Journal of B.U.ON. : official journal of the Balkan Union of Oncology , vol.22, no.4, pp.863-868, 2017

Ozaslan, E. Et Al. (2017) . "Efficacy and safety of cetuximab plus FOLFOX in second-line and third-line therapy in metastatic colorectal cancer.." Journal of B.U.ON. : official journal of the Balkan Union of Oncology , vol.22, no.4, pp.863-868.

@article{article, author={Ersin Ozaslan Et Al. }, title={Efficacy and safety of cetuximab plus FOLFOX in second-line and third-line therapy in metastatic colorectal cancer.}, journal={Journal of B.U.ON. : official journal of the Balkan Union of Oncology}, year=2017, pages={863-868} }